Lumexa Imaging Inc. Common Stock
LMRI | NASDAQ
$11.41
-$0.32 (-2.73%)
At close: Oct 30, 2026, 4:00 PM ET
$11.36
-$0.05 (-0.44%)
Pre-market:
Nov 2, 2026, 5:23 AM ET
Market Data
Market Cap $1.1B
Enterprise Value $2B
Beta 1.01
Average Volume 447.05K
Shares Outstanding (Diluted) 96.01M
Shares Change YoY 1.53%
Institutional Ownership 32.95%
Exchange NASDAQ
ISIN US5502491062
Price Performance
Price Change 1M 11.3%
Price Change 3M 9.6%
Price Change 6M 14.1%
Price Change YTD -38.3%
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 3.0%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR -42.1%
Valuation
PE Ratio -30.03
Forward PE 18.49
PEG Ratio 5.77
Forward PEG 0.05
PS Ratio 1.05
Forward PS 1.00
PB Ratio 1.78
P/FCF Ratio 34.43
P/Adj. FCF Ratio -54.65
P/OCF Ratio 17.03
EV/Sales 1.92
EV/EBIT 35.18
EV/EBITDA 17.97
EV/FCF 62.88
Earnings Yield -3.3%
FCF Yield 2.9%
Adj. FCF Yield -1.8%
Financial Health
Net Debt $792.17M
Total Debt $975.35M
Cash & Short-Term Investments $69.71M
Total Assets $1.81B
Current Ratio 1.44
Quick Ratio 1.44
Debt / Equity Ratio 1.59
Debt / EBITDA 8.75
Debt / FCF 30.64
OCF / Debt 0.07
Interest Coverage 0.16
Altman Z-Score 0.80
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 11.8%
Operating Profit Margin 1.4%
EBITDA Margin 11.0%
Net Profit Margin -2.7%
FCF Margin 3.0%
Adj. FCF Margin -1.9%
SBC / Revenue 5.0%
SBC Impact (per share) -163.0%
Returns
Return on Assets -1.5%
Return on Equity -5.6%
Return on Invested Capital 0.9%
Return on Capital Employed 0.9%
Return on Tangible Assets -2.9%
Analyst Forecasts
Analyst Rating Strong Buy
Analyst Count 2
EPS Growth Next 3Y 142.1%
Revenue Growth Next 3Y 6.2%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) $0.20
EPS Growth Est (next Q) -671.6%
Revenue Est (next Q) $270.27M
Revenue Growth Est (next Q) 3.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $16.40
Price Target Upside 43.7%
Cash Flow
Operating Cash Flow $64.7M
Free Cash Flow $31.84M
Adj. Free Cash Flow $-20.06M
FCF Per Share $0.33
OCF Per Share $0.67
OCF/S Ratio 6.2%
Income Statement
Revenue $1.04B
Gross Profit $123.08M
Operating Income $14.43M
EBITDA $111.42M
Net Income $-27.73M
EPS (Diluted) -$0.38
Revenue / Employee $208.68K
Profit / Employee $-5.55K
Employees 5,000
Add to Watchlist
Select watchlists to add or remove LMRI